INX International Ink Co. has completed an investment in Debut, a vertically integrated synthetic biology company that is developing innovative and complex active ingredients for natural colors, among other materials. Debut’s proprietary biomanufacturing platform uses “cell-free” and other advanced approaches, such as continuous biomanufacturing, to address the limitations of traditional methods, dramatically reducing the need for space, water, and expensive and unsustainable inputs. In ad...